title: Elliptocytosis in patients with C-terminal domain mutations of protein 4.1 correlates with encoded messenger RNA levels rather than with alterations in primary protein structure.
abstract: Early biochemical studies defined 4 functional domains of the erythroid protein 4.1 (4.1R). From amino-terminal to carboxy-terminal, these are 30 kd, 16 kd, 10 kd, and 22/24 kd in size. Although the functional properties of both the 30-kd and the 10-kd domain have been demonstrated in red cells, no functional activities have been assigned to either the 16-kd or the 22/24-kd domain in these cells. We here describe new mutations in the sequence encoding the C-terminal 22/24-kd domain that are associated with hereditary elliptocytosis. An unusually mild phenotype observed in heterozygous and homozygous members of 1 family suggested heterogeneity in the pattern of expression of 4.1R deficiency. Using a variety of protein and messenger RNA (mRNA) quantification strategies, we showed that, regardless of the alteration in the C-terminal primary sequence, when the protein is produced, it assembles at the cell membrane. In addition, we found that alterations in red cell morphologic features and membrane function correlate with the amount of membrane-associated protein-and therefore with the amount of mRNA accumulated-rather than with the primary structure of the variant proteins. These data suggest that an intact sequence at exons 19 through 21 encoding part of the C-terminal 22/24-kd region is not required for proper protein 4.1R assembly in mature red cells. (Blood. 2000;95:1834-1841)
authors.affiliation: CNRS URA 1171, Lyon, France; CNRS UMR 5534, Centre de Génétique Moléculaire et Cellulaire, Université Lyon 1, Villeurbanne, France.
authors.forename: M
authors.initials: M
authors.lastname: Morinière
authors.forename: L
authors.initials: L
authors.lastname: Ribeiro
authors.forename: N
authors.initials: N
authors.lastname: Dalla Venezia
authors.forename: M
authors.initials: M
authors.lastname: Deguillien
authors.forename: P
authors.initials: P
authors.lastname: Maillet
authors.forename: T
authors.initials: T
authors.lastname: Cynober
authors.forename: F
authors.initials: F
authors.lastname: Delhommeau
authors.forename: H
authors.initials: H
authors.lastname: Almeida
authors.forename: G
authors.initials: G
authors.lastname: Tamagnini
authors.forename: J
authors.initials: J
authors.lastname: Delaunay
authors.forename: F
authors.initials: F
authors.lastname: Baklouti
mesh_terms: D000328:Adult; D000595:Amino Acid Sequence; D003001:Cloning, Molecular; D003598:Cytoskeletal Proteins; D004252:DNA Mutational Analysis; D004612:Elliptocytosis, Hereditary / Q000235:genetics*; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008565:Membrane Proteins / Q000032:analysis / Q000737:chemistry / Q000235:genetics*; D008969:Molecular Sequence Data; D008970:Molecular Weight; D009479:Neuropeptides; D016133:Polymerase Chain Reaction; D018807:Polymorphism, Single-Stranded Conformational; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D012326:RNA Splicing; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics* / Q000378:metabolism; D013329:Structure-Activity Relationship
chemical_list: D003598:Cytoskeletal Proteins; D008565:Membrane Proteins; D009479:Neuropeptides; D012333:RNA, Messenger; C028841:erythrocyte membrane band 4.1 protein; C120557:erythrocyte membrane protein band 4.1-like 1